Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT
PDF
Cite
Share
Request
Interesting Image
E-PUB
11 November 2025

Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT

Mol Imaging Radionucl Ther. Published online 11 November 2025.
1. University of Health Sciences Türkiye Ankara Etlik City Hospital, Clinic of Nuclear Medicine, Ankara, Türkiye
No information available.
No information available
Received Date: 07.04.2025
Accepted Date: 17.08.2025
E-Pub Date: 11.11.2025
PDF
Cite
Share
Request

Abstract

A 49-year-old premenopausal woman with a history of left modified radical mastectomy and axillary lymph node dissection for invasive lobular carcinoma three years ago, underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) due to gradually increasing CA15-9 and CEA levels during routine follow-up. Compared with previous 18F-FDG PET/CT images, the left ovary in the current images showed increased size and radiotracer uptake. Subsequently, total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed, and histopathological evaluation confirmed unilateral metastasis in the left ovary due to primary breast cancer. Although rare, possible isolated ovarian metastasis should be considered in patients with breast cancer who have increased size and radiotracer uptake in ovarian tissue on follow-up 18F-FDG PET/CT scans.

Keywords:
Breast carcinoma, 18F-FDG PET/CT, unilateral ovarian metastasis, isolated ovarian metastasis, ovarian uptake

Ethics

Informed Consent: The informed consent was obtained from the patient.

Authorship Contributions

Surgical and Medical Practices: N.A.D., Concept: E.T., Design: D.Ç., Data Collection or Processing: Ö.Ö., Analysis or Interpretation: D.Ç., Ö.Ö., Literature Search: E.T., Writing: N.A.D.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
DiPiro PJ, Tirumani SH, Cruz GP, Ramaiya NH, Lester SC, Shinagare AB. Lobular breast cancer: patterns of intraabdominal metastatic spread on imaging and prognostic significance. Abdom Radiol (NY). 2019;44:362-369.
2
Kutasovic JR, McCart Reed AE, Males R, Sim S, Saunus JM, Dalley A, McEvoy CR, Dedina L, Miller G, Peyton S, Reid L, Lal S, Niland C, Ferguson K, Fellowes AP, Al-Ejeh F, Lakhani SR, Cummings MC, Simpson PT. Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study. J Pathol Clin Res. 2019;5:25-39.
3
Kubeček O, Laco J, Špaček J, Petera J, Kopecký J, Kubečková A, Filip S. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clin Exp Metastasis. 2017;34:295-307.
4
Roseland ME, Millet JD, Wasnik AP. Imaging of metastatic disease to the ovary/adnexa. Magn Reson Imaging Clin N Am. 2023;31:93-107.
5
Tian W, Zhou Y, Wu M, Yao Y, Deng Y. Ovarian metastasis from breast cancer: a comprehensive review. Clin Transl Oncol. 2019;21:819-827.
6
Pimentel C, Becquet M, Lavoue V, Henno S, Leveque J, Ouldamer L. Ovarian metastases from breast cancer: a series of 28 cases. Anticancer Res. 2016;36:4195-4200.
7
Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gonen M, Osborne JR, Jochelson M, Hudis C, Morrow M, Ulaner GA. Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma. J Nucl Med. 2015;56:1674-1680.